Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cellsJinshun Zhu, Lifang Zhang|Cell Death and Disease|2020Cited by 28
Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal CarcinomaSaidu Kamara, Lifang Zhang|Cells|2024Cited by 0